Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health information: verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
New Stroke Prevention Guidelines from the Stroke Council of the American Heart Association
Susan C. Fagan, Pharm.D., BCPS, FCCP
June, 2006
Article: Sacco RL, Adams R, Albers G, et. al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Feb;37(2):577-617.
The long-awaited update of the Stroke Council's 1999 secondary stroke prevention guidelines1 were published in February of 2006. In contrast to the predecessor, the new guidelines are much more comprehensive, are evidence-based and each recommendation is given a grade for the strength of the supporting evidence. In the new guidelines, it is recommended that TIA and stroke be treated with equal urgency and aggressiveness and an approach that lessens the risk of ALL vascular events (not just ischemic stroke) is recommended. There are no big surprises in the guidelines and they are consistent with other published guidelines dealing with vascular risk reduction. Risk factor control, including hypertension, diabetes and lipids are included as well as recommendations regarding physical activity, smoking cessation and alcohol. In addition, specific pharmacologic and surgical interventions are recommended for patients with specific etiologic conditions. The strongest recommendations (level A) are made for:
-
Antihypertensive treatment
-
Diabetes control
-
Statin therapy
-
Carotid endarterectomy for large artery atherosclerosis
-
Warfarin for atrial fibrillation
-
Antiplatelet therapy for noncardioembolic stroke or TIA
Reference
1. Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999 Sep;30(9):1991-4.
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
|
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
|
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Saturday, August 31, 2024
|